182 related articles for article (PubMed ID: 20549891)
1. [Does nasal decontamination reduce the incidence of infections after cardiac surgery?].
Jabbour H; Madi-Jebara S; Jabbour K; Yazigi A; Haddad F; Hayek G; Yazbeck P; Antakly MC
J Med Liban; 2010; 58(2):65-70. PubMed ID: 20549891
[TBL] [Abstract][Full Text] [Related]
2. Controlling the usage of intranasal mupirocin does impact the rate of Staphylococcus aureus deep sternal wound infections in cardiac surgery patients.
Nicholson MR; Huesman LA
Am J Infect Control; 2006 Feb; 34(1):44-8. PubMed ID: 16443093
[TBL] [Abstract][Full Text] [Related]
3. Randomized clinical trial of preoperative intranasal mupirocin to reduce surgical-site infection after digestive surgery.
Suzuki Y; Kamigaki T; Fujino Y; Tominaga M; Ku Y; Kuroda Y
Br J Surg; 2003 Sep; 90(9):1072-5. PubMed ID: 12945073
[TBL] [Abstract][Full Text] [Related]
4. Safety of targeted perioperative mupirocin treatment for preventing infections after cardiac surgery.
Shrestha NK; Banbury MK; Weber M; Cwynar RE; Lober C; Procop GW; Karafa MT; Gordon SM
Ann Thorac Surg; 2006 Jun; 81(6):2183-8. PubMed ID: 16731151
[TBL] [Abstract][Full Text] [Related]
5. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections.
Perl TM; Cullen JJ; Wenzel RP; Zimmerman MB; Pfaller MA; Sheppard D; Twombley J; French PP; Herwaldt LA;
N Engl J Med; 2002 Jun; 346(24):1871-7. PubMed ID: 12063371
[TBL] [Abstract][Full Text] [Related]
6. Long-term efficacy of intranasal mupirocin ointment. A prospective cohort study of Staphylococcus aureus carriage.
Doebbeling BN; Reagan DR; Pfaller MA; Houston AK; Hollis RJ; Wenzel RP
Arch Intern Med; 1994 Jul; 154(13):1505-8. PubMed ID: 8018006
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy of mupirocin in the prevention of infections with meticillin-resistant Staphylococcus aureus in a gastroenterology unit.
Dupeyron C; Campillo B; Richardet JP; Soussy CJ
J Hosp Infect; 2006 Aug; 63(4):385-92. PubMed ID: 16772100
[TBL] [Abstract][Full Text] [Related]
8. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
Fawley WN; Parnell P; Hall J; Wilcox MH
J Hosp Infect; 2006 Mar; 62(3):327-32. PubMed ID: 16377029
[TBL] [Abstract][Full Text] [Related]
9. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
10. [Use of nasal mupirocin for Staphylococcus aureus: effect on nasal carriers and nosocomial infections].
García AM; Villa MV; Escudero ME; Gómez P; Vélez MM; Múnera MI; Franco G
Biomedica; 2003 Jun; 23(2):173-9. PubMed ID: 12872556
[TBL] [Abstract][Full Text] [Related]
11. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
12. Reduction of preoperative conjunctival bacterial flora with the use of mupirocin nasal ointment.
Alexandrou TJ; Hariprasad SM; Benevento J; Rubin MP; Saidel M; Ksiazek S; Thompson K; Boonlayangoor S; Mieler WF
Trans Am Ophthalmol Soc; 2006; 104():196-201. PubMed ID: 17471340
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sézary syndrome.
Talpur R; Bassett R; Duvic M
Br J Dermatol; 2008 Jul; 159(1):105-12. PubMed ID: 18489588
[TBL] [Abstract][Full Text] [Related]
14. Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment.
Coskun D; Aytac J
J Hosp Infect; 2004 Sep; 58(1):90-1. PubMed ID: 15350723
[No Abstract] [Full Text] [Related]
15. Risk Factors for Methicillin-Resistant Staphylococcus aureus (MRSA) and Use of a Nasal Mupirocin Ointment in Oral Cancer Inpatients.
Miyake M; Ohbayashi Y; Iwasaki A; Ogawa T; Nagahata S
J Oral Maxillofac Surg; 2007 Nov; 65(11):2159-63. PubMed ID: 17954308
[TBL] [Abstract][Full Text] [Related]
16. Sustained reduction in methicillin-resistant Staphylococcus aureus wound infections after cardiothoracic surgery.
Walsh EE; Greene L; Kirshner R
Arch Intern Med; 2011 Jan; 171(1):68-73. PubMed ID: 20837818
[TBL] [Abstract][Full Text] [Related]
17. Methicillin-resistant Staphylococcus aureus preventing strategy in cardiac surgery.
Mastoraki A; Kriaras I; Douka E; Mastoraki S; Stravopodis G; Geroulanos S
Interact Cardiovasc Thorac Surg; 2008 May; 7(3):452-6. PubMed ID: 18346978
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review.
Laupland KB; Conly JM
Clin Infect Dis; 2003 Oct; 37(7):933-8. PubMed ID: 13130405
[TBL] [Abstract][Full Text] [Related]
19. Dose-ranging study to assess the application of intranasal 2% mupirocin calcium ointment to eradicate Staphylococcus aureus nasal colonization.
Mehta MS; Hacek DM; Kufner BA; Price C; Peterson LR
Surg Infect (Larchmt); 2013 Feb; 14(1):69-72. PubMed ID: 23448592
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.
Pérez-Fontán M; Rosales M; Rodríguez-Carmona A; Moncalián J; Fernández-Rivera C; Cao M; Valdés F
Adv Perit Dial; 1992; 8():242-5. PubMed ID: 1361797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
